Last reviewed · How we verify
REN-1654
At a glance
| Generic name | REN-1654 |
|---|---|
| Sponsor | Renovis |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia (PHASE2)
- Study of REN-1654 in Patients With Sciatica Pain (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |